128 related articles for article (PubMed ID: 25084760)
21. Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease.
Nordestgaard LT; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
Alzheimers Dement; 2015 Dec; 11(12):1430-1438. PubMed ID: 26079414
[TBL] [Abstract][Full Text] [Related]
22. Astrocyte Elevated Gene-1 (AEG-1) Regulates Lipid Homeostasis.
Robertson CL; Srivastava J; Siddiq A; Gredler R; Emdad L; Rajasekaran D; Akiel M; Shen XN; Corwin F; Sundaresan G; Zweit J; Croniger C; Gao X; Ghosh S; Hylemon PB; Subler MA; Windle JJ; Fisher PB; Sarkar D
J Biol Chem; 2015 Jul; 290(29):18227-18236. PubMed ID: 26070567
[TBL] [Abstract][Full Text] [Related]
23. Brain metabolomics in rats after administration of ketamine.
Wen C; Zhang M; Zhang Y; Sun F; Ma J; Hu L; Lin G; Wang X
Biomed Chromatogr; 2016 Jan; 30(1):81-4. PubMed ID: 26014584
[TBL] [Abstract][Full Text] [Related]
24. Physiological changes during fasting in Ramadan.
Meo SA; Hassan A
J Pak Med Assoc; 2015 May; 65(5 Suppl 1):S6-S14. PubMed ID: 26013791
[TBL] [Abstract][Full Text] [Related]
25. The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid.
Crick PJ; Beckers L; Baes M; Van Veldhoven PP; Wang Y; Griffiths WJ
Steroids; 2015 Jul; 99(Pt B):172-7. PubMed ID: 25759118
[TBL] [Abstract][Full Text] [Related]
26. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation of cholesterol homeostasis.
Meaney S
Front Genet; 2014; 5():311. PubMed ID: 25309573
[TBL] [Abstract][Full Text] [Related]
28. Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments.
Zheng W; Mast N; Saadane A; Pikuleva IA
J Lipid Res; 2015 Jan; 56(1):81-97. PubMed ID: 25293590
[TBL] [Abstract][Full Text] [Related]
29. Cholestenoic acids regulate motor neuron survival via liver X receptors.
Theofilopoulos S; Griffiths WJ; Crick PJ; Yang S; Meljon A; Ogundare M; Kitambi SS; Lockhart A; Tuschl K; Clayton PT; Morris AA; Martinez A; Reddy MA; Martinuzzi A; Bassi MT; Honda A; Mizuochi T; Kimura A; Nittono H; De Michele G; Carbone R; Criscuolo C; Yau JL; Seckl JR; Schüle R; Schöls L; Sailer AW; Kuhle J; Fraidakis MJ; Gustafsson JÅ; Steffensen KR; Björkhem I; Ernfors P; Sjövall J; Arenas E; Wang Y
J Clin Invest; 2014 Nov; 124(11):4829-42. PubMed ID: 25271621
[TBL] [Abstract][Full Text] [Related]
30. Analysis of aquaporin 9 expression in human epidermis and cultured keratinocytes.
Sugiyama Y; Yamazaki K; Kusaka-Kikushima A; Nakahigashi K; Hagiwara H; Miyachi Y
FEBS Open Bio; 2014; 4():611-6. PubMed ID: 25161869
[TBL] [Abstract][Full Text] [Related]
31. Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond.
Moutinho M; Nunes MJ; Rodrigues E
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1911-1920. PubMed ID: 27663182
[TBL] [Abstract][Full Text] [Related]
32. Effects of Complete and Partial Loss of the 24S-Hydroxycholesterol-Generating Enzyme
Shu HJ; Ziolkowski LH; Salvatore SV; Benz AM; Wozniak DF; Yuede CM; Paul SM; Zorumski CF; Mennerick S
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540675
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis.
Tsitsou-Kampeli A; Suzzi S; Kenigsbuch M; Satomi A; Strobelt R; Singer O; Feldmesser E; Purnapatre M; Colaiuta SP; David E; Cahalon L; Hahn O; Wyss-Coray T; Shaul Y; Amit I; Schwartz M
Cell Rep Med; 2023 Nov; 4(11):101278. PubMed ID: 37944529
[TBL] [Abstract][Full Text] [Related]
34. Altered Cholesterol Homeostasis in Huntington's Disease.
Kacher R; Mounier C; Caboche J; Betuing S
Front Aging Neurosci; 2022; 14():797220. PubMed ID: 35517051
[TBL] [Abstract][Full Text] [Related]
35. Defects of Nutrient Signaling and Autophagy in Neurodegeneration.
Ondaro J; Hernandez-Eguiazu H; Garciandia-Arcelus M; Loera-Valencia R; Rodriguez-Gómez L; Jiménez-Zúñiga A; Goikolea J; Rodriguez-Rodriguez P; Ruiz-Martinez J; Moreno F; Lopez de Munain A; Holt IJ; Gil-Bea FJ; Gereñu G
Front Cell Dev Biol; 2022; 10():836196. PubMed ID: 35419363
[TBL] [Abstract][Full Text] [Related]
36. Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases.
Pikuleva IA
Explor Neuroprotective Ther; 2021 Dec; 1(3):159-172. PubMed ID: 35156102
[TBL] [Abstract][Full Text] [Related]
37. LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1.
Patel D; Ahmad F; Kambach DM; Sun Q; Halim AS; Kramp T; Camphausen KA; Stommel JM
Sci Rep; 2019 Oct; 9(1):15458. PubMed ID: 31664073
[TBL] [Abstract][Full Text] [Related]
38. The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.
Petrov AM; Mast N; Li Y; Pikuleva IA
FASEB J; 2019 Aug; 33(8):8782-8798. PubMed ID: 31063705
[TBL] [Abstract][Full Text] [Related]
39. CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.
Petrov AM; Lam M; Mast N; Moon J; Li Y; Maxfield E; Pikuleva IA
Neurotherapeutics; 2019 Jul; 16(3):710-724. PubMed ID: 31062296
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
